Furthermore, analysis of immune cells in the tumor revealed a significant increase in the number of DCs (Figure 4(q)) and IFN-γ+CD8 T cells (Figure 4(r)) in response to MNC-168 MVs treatment. Here, CD8A is linked to neoplasm.